Shin Nippon Biomedical Laboratories, Ltd. Stock: price and insider trades · Japan
株式会社新日本科学
No insider purchase over the last 90 days. The latest, by Nagata and Company Inc., was filed 04 Jun 2024.
Shin Nippon Biomedical Laboratories, Ltd.: what insiders have been doing
Shin Nippon Biomedical Laboratories, Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to EDINET (Japan FSA). 2 insiders have disclosed 2 filings since 8 November 2025.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
For context, the typical company on the same exchange (median of 3,205 companies) published 3 filings over the same period, against 2 filings here. Since 2022, the database holds 1 purchase and no sales by insiders of the company.
No insider has bought Shin Nippon Biomedical Laboratories, Ltd. shares on the open market in the past twelve months.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. This summary is built from EDINET (Japan FSA) disclosures alone and does not predict where the share price will go.
Since the insiders bought
- -5.7%Entry JP¥1,368 · Close at T+365 JP¥1,290
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 34.7% of flowShareXTKSEDINET:S100Y05J
- ShareXTKSEDINET:S100X8OU
- ShareXTKSEDINET:S100WN8I
- 38.2% of flowShareXTKSEDINET:S100TJF9
- 1,024,000 shares@ JP¥1,307.00100.0% of flowShareXOFFEDINET:S100TJF9:T1Canonical exit: 26 Aug 2024 (T+90)
- 27.1% of flowShareXTKSEDINET:S100SHBT
- ●Unknown10EDINET50.1% of flowShareXTKSEDINET:S100NXB8
7 of 7 declarations
About Shin Nippon Biomedical Laboratories, Ltd.
株式会社新日本科学 is a Japanese company focused on research and development in the health and pharmaceutical sector. It is listed on the XTKS market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
